Peripheral Spondyloarthritis: Demystifying the Ambiguity!
Indian Journal of Rheumatology · 2026-06 · 21 (2) · 179-187
DOI: 10.1177/09733698261438188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Rheumatology, online erschienen am 12.04.2026. Verfasst von Sankar J. und 3 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Peripheral spondyloarthritis (pSpA) includes many cases of PsA, ReA, IBD-SpA, and a subset without features of psoriasis, IBD and preceding infection, referred to as ‘pure’ pSpA. It is well documented that peripheral manifestations contribute considerably to the morbidity of SpA. However, despite a lot of advances in the treatment of axSpA with the introduction of newer biological agents targeting IL-17, IL-23, and JAK pathways, pSpA (excluding psoriatic arthritis) remains an area devoid of much research, with only a few clinical trials. In this narrative review, we tried to look into this entity of pSpA, excluding psoriatic arthritis (non-psoriatic pSpA). Future studies should focus on genetics, the development of specific biomarkers, exclusive classification criteria, specific outcome measures, imaging modalities and randomised control trials in pSpA.
Zitieren
APA
J., S., Dhir, V., Prasad, C. B., & Leishangthem, B. (2026). Peripheral Spondyloarthritis: Demystifying the Ambiguity!. Indian Journal of Rheumatology, 21(2), 179-187. https://doi.org/10.1177/09733698261438188
Vancouver
J. S, Dhir V, Prasad CB, Leishangthem B. Peripheral Spondyloarthritis: Demystifying the Ambiguity!. Indian Journal of Rheumatology. 2026;21(2):179-187. doi:10.1177/09733698261438188
BibTeX
@article{J2026,
author = {J., Sankar and Dhir, Varun and Prasad, Chandra Bhushan and Leishangthem, Bidyalaxmi},
title = {Peripheral Spondyloarthritis: Demystifying the Ambiguity!},
journal = {Indian Journal of Rheumatology},
year = {2026},
volume = {21},
number = {2},
pages = {179--187},
doi = {10.1177/09733698261438188}
}
EUVIMED